The Differential Effect of Treadmill Exercise Intensity on Hippocampal Soluble Aβ and Lipid Metabolism in APP/PS1 Mice

[1]  G. Ricci.  Social Aspects of Dementia Prevention from a Worldwide to National Perspective: A Review on the International Situation and the Example of Italy , 2019, Behavioural neurology.

[2]  Diana C. Rostirolla,et al.  Nuclear RXRα and RXRβ receptors exert distinct and opposite effects on RA-mediated neuroblastoma differentiation. , 2019, Biochimica et biophysica acta. Molecular cell research.

[3]  YingChun Liu,et al.  Effect of retinoid X receptor-α nuclear export inhibition on apoptosis of neurons in vivo and in vitro. , 2017, Molecular medicine reports.

[4]  Alina Solomon,et al.  Physical Activity and Alzheimer’s Disease: A Systematic Review , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  H. Moreno,et al.  Role of Liver X Receptor in AD Pathophysiology , 2015, PloS one.

[6]  R. Morishita,et al.  The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease , 2015, Front. Aging Neurosci..

[7]  X. Tong,et al.  Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice , 2015, Neuroscience.

[8]  C. Cotman,et al.  Moderate to high-intensity physical exercise in patients with Alzheimer’s disease , 2015, Alzheimer's & Dementia.

[9]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[10]  M. Carrillo,et al.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective , 2015, Alzheimer's & Dementia.

[11]  Minna Rusanen,et al.  Leisure-time physical activity from mid- to late life, body mass index, and risk of dementia , 2015, Alzheimer's & Dementia.

[12]  Juan Zhang,et al.  Cholesterol metabolism and homeostasis in the brain , 2015, Protein & Cell.

[13]  Kristine Yaffe,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[14]  B. Schreurs,et al.  Dietary cholesterol increases ventricular volume and narrows cerebrovascular diameter in a rabbit model of Alzheimer’s disease , 2013, Neuroscience.

[15]  J. Pozueta,et al.  Synaptic changes in Alzheimer’s disease and its models , 2013, Neuroscience.

[16]  Carl W. Cotman,et al.  Exercise counteracts declining hippocampal function in aging and Alzheimer's disease , 2013, Neurobiology of Disease.

[17]  R. Steiner,et al.  Sterol metabolism disorders and neurodevelopment-an update. , 2013, Developmental disabilities research reviews.

[18]  Michael T. Heneka,et al.  PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice , 2012, The Journal of Neuroscience.

[19]  J. Vance.  Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases , 2012, Disease Models & Mechanisms.

[20]  S. Rivest,et al.  Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors. , 2012, Endocrine reviews.

[21]  V. Pankratz,et al.  Computer activities, physical exercise, aging, and mild cognitive impairment: a population-based study. , 2012, Mayo Clinic proceedings.

[22]  D A Bennett,et al.  Total daily physical activity and the risk of AD and cognitive decline in older adults , 2012, Neurology.

[23]  L. Yágüez,et al.  The effects on cognitive functions of a movement‐based intervention in patients with Alzheimer's type dementia: a pilot study , 2011, International journal of geriatric psychiatry.

[24]  J. Viña,et al.  Cholesterol and amyloid-β: evidence for a cross-talk between astrocytes and neuronal cells. , 2011, Journal of Alzheimer's disease : JAD.

[25]  N. Fitz,et al.  The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration. , 2010, Biochimica et biophysica acta.

[26]  K. Yaffe,et al.  Physical Activity Over the Life Course and Its Association with Cognitive Performance and Impairment in Old Age , 2010, Journal of the American Geriatrics Society.

[27]  A. Tall,et al.  Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[28]  J. Buxbaum,et al.  APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice. , 2010, Journal of Alzheimer's disease : JAD.

[29]  Katie Hamm,et al.  apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. , 2008, The Journal of clinical investigation.

[30]  S. Andersson,et al.  Neuronal expression and subcellular localization of cholesterol 24‐hydroxylase in the mouse brain , 2008, The Journal of comparative neurology.

[31]  D. Holtzman,et al.  Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. , 2008, The Journal of clinical investigation.

[32]  J. Repa,et al.  Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse , 2007, The Journal of Neuroscience.

[33]  I. Lefterov,et al.  Role of LXR and ABCA1 in the pathogenesis of Alzheimer's disease - implications for a new therapeutic approach. , 2007, Current Alzheimer research.

[34]  K. Fukuchi,et al.  Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice , 2006, Neurobiology of Aging.

[35]  J. Dietschy,et al.  Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.

[36]  K. Weisgraber,et al.  Cholesterol Published, JLR Papers in Press, January 23, 2003. DOI 10.1194/jlr.R300007-JLR200 , 2003, Journal of Lipid Research.

[37]  K. Fassbender,et al.  Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide , 2002, Neurology.

[38]  J. Leverenz,et al.  Diet-induced hypercholesterolemia enhances brain A&bgr; accumulation in transgenic mice , 2002, Neuroreport.

[39]  Yonghe Li,et al.  Differential Functions of Members of the Low Density Lipoprotein Receptor Family Suggested by Their Distinct Endocytosis Rates* , 2001, The Journal of Biological Chemistry.

[40]  Rong Wang,et al.  Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model , 2000, Neurobiology of Disease.

[41]  Y. Rolland,et al.  Feasibility [corrected] of regular physical exercise for patients with moderate to severe Alzheimer disease. , 2000, The journal of nutrition, health & aging.

[42]  W. Klein,et al.  Cholesterol Modulates -Secretase Cleavage of Amyloid Precursor Protein (*) , 1996, The Journal of Biological Chemistry.

[43]  J. Dallongeville,et al.  Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. , 1992, Journal of lipid research.